The Patent Trial and Appeal Board has instituted four of the Coalition for Affordable Drugs’ IPR petitions challenging Celgene patents, bringing the total number its petitions instituted to seven and greatly shifting the success rate of what one law firm calls the “PTAB Crashers”
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
A CJEU copyright decision on employees' rights and an update on an IP feud concerning foreign rights over 'Superman' were also among the top talking points
EIP also emerged victorious as the England and Wales Court of Appeal backed a challenge brought by Avanci and InterDigital against the electric carmaker
Madeleine Kelly, the Australia-based IP firm’s new managing partner, discusses its new advisory offering, a promising fresh hire and changing market dynamics